Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 2/2015

01-06-2015 | Original Article

Prevalence of depression in patients with type 2 diabetes mellitus in Irish primary care and the impact of depression on the control of diabetes

Authors: E. Foran, A. Hannigan, L. Glynn

Published in: Irish Journal of Medical Science (1971 -) | Issue 2/2015

Login to get access

Abstract

Background

As the Irish population ages, the management of chronic conditions in primary care is emerging as a challenge. The presence of co-morbid depression is common among such patients and may affect their response to treatment.

Aims

This study sought to determine whether the prevalence of depression is higher in patients with type 2 diabetes mellitus than in the population aged >50 in the West of Ireland, and whether depression is an independent predictor of diabetes control.

Methods

We used a cross-sectional design to examine an anonymized database of 9,698 patients aged >50 years whose medical data were collected as part of NUI Galway’s CLARITY study. Glycosylated HbA1c levels were used to estimate type 2 DM control; depression was assessed using the Hospital Anxiety and Depression Scale.

Results

We found that while there is a higher prevalence of severe depression in patients with type 2 DM, there is no association between their diabetes control and depression after controlling for age, gender, comorbidity and GMS status. Multimorbidity is a significant predictor of depression in both diabetic and non-diabetic populations, with the odds of depression increasing as the number of co-morbidities increased.

Conclusions

Patients with type 2 DM are more likely to suffer from severe depression than those without. Depression itself is not an independent predictor of diabetes control. However, it may be that the increased rates of depression observed in patients with type 2 DM are at least partially attributable to the burden of additional illnesses seen in these patients.
Literature
1.
go back to reference Balanda KP, Jordan A, McArdle E (2006) Making diabetes count. A systematic approach to estimating population prevalence on the island of Ireland in 2005. The Institute of Public Health in Ireland Balanda KP, Jordan A, McArdle E (2006) Making diabetes count. A systematic approach to estimating population prevalence on the island of Ireland in 2005. The Institute of Public Health in Ireland
2.
go back to reference Ciechanowksi PS, Katon WJ, Russo JE et al (2003) The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry 25:246–252CrossRef Ciechanowksi PS, Katon WJ, Russo JE et al (2003) The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry 25:246–252CrossRef
3.
go back to reference Anderson RJ, Freedland KE, Clouse RE et al (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069–1078CrossRefPubMed Anderson RJ, Freedland KE, Clouse RE et al (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069–1078CrossRefPubMed
4.
go back to reference DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160:2101–2107CrossRefPubMed DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160:2101–2107CrossRefPubMed
7.
8.
go back to reference Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370CrossRefPubMed Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370CrossRefPubMed
9.
go back to reference Bjelland I, Dahl AA, Haug TT et al (2002) The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res 52(2):69–77CrossRefPubMed Bjelland I, Dahl AA, Haug TT et al (2002) The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res 52(2):69–77CrossRefPubMed
10.
go back to reference Lustman PJ, Griffith LS, Freedland KE et al (1997) The course of major depression in diabetes. Gen Hosp Psychiatry 19:138–143CrossRefPubMed Lustman PJ, Griffith LS, Freedland KE et al (1997) The course of major depression in diabetes. Gen Hosp Psychiatry 19:138–143CrossRefPubMed
11.
go back to reference Knol MJ, Heerdink ER, Egberts ACG et al (2007) Depressive symptoms in subjects with diagnosed and undiagnosed type 2 diabetes. Psychosom Med 69:300–305CrossRefPubMed Knol MJ, Heerdink ER, Egberts ACG et al (2007) Depressive symptoms in subjects with diagnosed and undiagnosed type 2 diabetes. Psychosom Med 69:300–305CrossRefPubMed
13.
go back to reference NICE clinical guideline 66 (2008) Type 2 diabetes: the management of type 2 diabetes NICE clinical guideline 66 (2008) Type 2 diabetes: the management of type 2 diabetes
14.
go back to reference Lustman PJ, Clouse RE (2005) Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 19:113–122PubMed Lustman PJ, Clouse RE (2005) Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 19:113–122PubMed
Metadata
Title
Prevalence of depression in patients with type 2 diabetes mellitus in Irish primary care and the impact of depression on the control of diabetes
Authors
E. Foran
A. Hannigan
L. Glynn
Publication date
01-06-2015
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 2/2015
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-014-1110-7

Other articles of this Issue 2/2015

Irish Journal of Medical Science (1971 -) 2/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.